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INTRODUCTION
Obesity is one of the major health challenges of the 21st century (Phyllis et al., 2005; Alizadeh et al., 2013) . Children and adolescents with obesity are at a high risk of developing obesity-related diseases such as cardio-vascular diseases, arterial hypertension (AH), dyslipidemia, metabolic syndrome (MS), type 2 diabetes mellitus (T2DM), different types of tumours, orthopedic problems, and serious psychological and neurological problems, etc. (Phyllis et al., 2005; Halpern et al., 2010; Alizadeh et al., 2013) .
The number of adolescents being diagnosed with T2DM is increasing in America, Europe, Japan and Australia (Phyllis et al., 2005) . Increase of T2DM among adolescents is attributed to spread of unhealthy habits, increasing obesity among children and teenagers, and better diagnostics. (Halpern et al., 2010) . Unfortunately, no study on T2DM has been done in Latvia in recent years.
Diabetes-related morbidity is caused by microvascular and macrovascular complications, which lead to early disability and premature death (Pinhas-Hamiel et al., 2007) . Even at the moment of diagnosing T2DM, patients can already have serious comorbidities, such as arterial hypertension, dyslipidemia, fatty liver etc. (Rosenbloom et al., 2008) . Halpern et al., 2010; Alizadeh et al., 2013) .
The American Academy of Pediatrics and the American Diabetes Association recommend T2DM screening for adolescents who are overweight and who have two of the following risk factors: a first or second-degree relative with diagnosed type 2 diabetes; those belonging to ethnic populations with increased risk (e.g., African-American, American Indians, Asian and Pacific Islander ethnicities); those with one of the symptoms related to insulin resistanceacanthosis nigricans, arterial hypertension, dyslipidemia or polycystic ovary (PCO) syndrome. The screening commences either at 10 years of age or at the onset of puberty (if it is premature), and is repeated every two years. The first examination when starting screening for T2DM in adolescents is measurement of fasting glucose. However, the more accurate, but also more cumbersome examination is the oral glucose tolerance test (OGTT) (Phyllis et al., 2005) .
Considering that there have not been any studies looking at T2DM epidemiology in children, our study was aimed to identify children groups with type 2 diabetes mellitus or impaired glucose tolerance and associated comorbidities at the moment of establishing diagnosis. The study was conducted at the Children's Clinical University Hospital in Latvia.
MATERIALS AND METHODS
Samples, anthropometry and blood tests. A retrospective analysis was performed of all children with type 2 diabetes mellitus or glucose tolerance impairment, who were treated in Children's Endocrinology Centre at the Children's Clinical University Hospital Riga from 2002 till 2013. In total 57 patient cases with impaired glucose tolerance (IGT) or type 2 diabetes mellitus (T2DM) were analysed and they represented only 1.38% of all patients treated in the Children's Endocrinology centre during that period. All 57 patients had been hospitalised to perform type 2 diabetes mellitus screening using the oral glucose tolerance test (OGTT). After a 12-h overnight fasting, the subjects underwent an OGTT at 08.00 a.m. Glucose was given orally (1.75 g/kg body weight, up to a maximum of 75 g glucose). Blood samples were drawn after 30, 60, 90, and 120 min. Diagnosis of IGT was made if the blood glucose level after 2 hours was ³ 7.8-11.0 mmol/l. Diagnosis of T2DM was made if fasting glucose was ³ 7.0 mmol/l in venous plasma, or two-hour glucose during OGTT was ³ 11.1 mmol/l in venous plasma (Wiegand et al., 2004) .
In our descriptive retrospective study, we analysed and summarised patient weight, height, age and blood pressure (BP) rates during hospitalisation. The body mass index (BMI) was calculated using the formula weight (kg)/height (m) 2 and evaluated using percentile charts adjusted to age and gender. Baseline test results were obtained for measurement of fasting (venous) thyroid-stimulating hormone (TSH), total cholesterol (TC), triglycerides (TG), high-density lipoprotein (HDL), low-density lipoprotein (LDL), alanine aminotransferase (ALT), aspartate aminotransferase (AST), glucose and C-peptide.
Blood pressure measurements were assessed according to percentile charts for the relevant age, height and gender. Arterial hypertension was diagnosed if the systolic and/or diastolic blood pressure in the > 95 percentile in three repeated measurements (Dinesh et al., 2012) .
Dyslipidemia was diagnosed using the criteria developed by the National Institutes of Health Heart, Lung and Blood Institute (NHLBI): TC ³ 5.2 mmol/l, TG ³ 1.5 mmol/l, LDL ³ 3.4 mmol/l, HDL < 1.00 mmol/l (Yoon, 2014) .
The Ethics Committee of the Rîga Stradiòð University approved the study.
Statistical analysis. In our study we used nonparametric statistics descriptive indicators -median, quartiles, interquartile range. Groups were compared with the MannWhitney test. A probability value of less than 0.05 was considered significant. Statistical analysis was performed using IBM SPSS Statistics for Windows, version 22.0.
RESULTS
In total, there were 57 patients included in the study. There were 24 (7 boys (29%) and 17 girls (71%)) diagnosed with type 2 diabetes mellitus, while 33 patients (21 boy (63%) and 12 girls (37%)) had impaired glucose tolerance. Median age in the T2DM group was 15 (13.3-17.0 years), in impaired glucose tolerance group -14 (12.0-16.0). There was no statistically significant age difference between the groups (p = 0.912).
All included children had elevated BMI. In the T2DM group, all children had elevated BMI above the 99 th percentile and were deemed obese. In the impaired glucose tolerance group, there were four overweight children (BMI above 85th percentile), while the others had above the 95 th percentile.
There was a statistically significant (p < 0.001) diastolic blood pressure difference between the groups -in the T2DM group median diastolic blood pressure was 85 mmHg (75-90 mmHg), while in the IGT group -80 mmHg (72-90 mmHg). Laboratory parameters revealed a statistically significantly (p = 0.011) lower HDL in the T2DM group (Table 1) .
Girls with T2DM had significantly higher total cholesterol (median 5.2 mmol/l (4.5-5.5)) than girls in the IGT group (median 4.1 mmol/l (3.3-4.9)) (p = 0.02). Also, LDL was significantly higher in T2DM girls (p = 0.003), than in girls in the IGT group (Table 2 ).
There was a statistically significant difference between the groups (p = 0.035) in BMI of boys -in the T2DM group median BMI in boys was 31.3 kg/m 2 (30.8-40.4), while in the IGT group -25.9 kg/m 2 (18.9-35.2). There were no statistically significant differences in other parameters between the groups in boys (Table 3) .
At the time of diagnosis, arterial hypertension was found in 16 (66.7%) of T2DM patients and 18 (54.5%) patients with IGT. There were no statistically significant differences found between the groups concerning arterial hypertension (p = 0.28).
At the time of diagnosis, 13 (54.2%) T2DM patients and 5 (15.2%) IGT patients had dyslipidemia, and this difference was statistically significant between the groups (p = 0.03).
DISCUSSION
Numerous studies and observations have been carried out investigating excess weight, impaired glucose tolerance and type 2 diabetes mellitus in children (Eyzaguirre et al., 2009; Huang et al., 2009 ). There are many modifiable and non-modifiable risk factors for childhood obesity. This is important because prevention of childhood obesity reduces the possibility of developing IGT and T2DM ( Maahs et al., 2008; Huang et al., 2009 tions (Copeland et al., 2011) .The following risk factors are considered for T2DM in children -obesity, family history of diabetes, female gender and low socioeconomic status. (Copeland et al., 2011) .
In our study at the time of hospitalisation all patients were overweight, so IGT/T2DM screening was initiated. Most of the patients with T2DM diagnosis were girls (71%, n = 17). In our study we did not analyse other risk factors, such as positive diabetes family history and socioeconomic status.
In young people T2DM is diagnosed more frequently during the second decade of life and the average age of diagnosis is 13.5, coinciding with the physiological peak of insulin resistance (Ball et al., 2006) . In our study median age in patients with T2DM was 15, which means that diabetes screening in children was performed early enough.
The type 2 diabetes diagnosed in adolescence is more frequently associated with medical conditions other than type 1 diabetes (T1D) (Godoy-Matos et al., 2005; Eppens et al., 2006; Kershnar et al., 2006; Pinhas-Hamiel et al., 2007; Önal et al., 2014) . Microvascular complications (retinopathy), nephropathy, peripheral neuropathy and macrovascular complications affect the quality of life as well as long term morbidity and mortality. Many studies have shown that the risk of arterial hypertension and dyslipidemia is much higher in patients with T2DM than in patients with T1DM (Godoy-Matos et al., 2005) . A multicentre study in USA showed that arterial hypertension was found in 10-32% of patients with T2DM and was eight times more likely than in patients with T1DM in the same age group. Isolated or combined dyslipidemia was found in 24-44% of cases (Kershnar et al., 2006) . In our study dyslipidemia was found in 54.2% and arterial hypertension in 66.7% of children at T2DM diagnosis.
This finding is very alarming, because children with T2DM and other cardiovascular risk factors, such as arterial hypertension, have drastically increased cardiovascular and premature death risk. Considering that average cardiovascular disease mortality in Latvia is higher in women (6%) than men, more attention has to be directed to girls with excess weight (Ðtâle et al., 2012) . Our study showed significantly higher total cholesterol and low-density lipoprotein levels in girls with T2DM, which is associated with increased cardiovascular disease risk. The treatment should not only focus on normalising glucose levels, but also on controlling comorbidities.
The basic treatment goals for children and adolescents with T2DM are: psychologic and family support therapy, weight reduction; lifestyle corrections -balanced diet and increased physical activity. The next step is achieving normal glucose levels and controlling comorbidities, including hypertension, dyslipidemia and hepatic steatosis (GodoyMatos et al., 2005; Phyllis et al., 2005; Maahs et al., 2008; Huang et al., 2009 ). This strategy would be especially important to children with impaired glucose tolerance.
Adult studies have shown, that lifestyle corrections are more effective than pharmacotherapy in preventing T2DM in patients with impaired glucose tolerance. Pharmacotherapy is very limited in children with T2DM, and the only approved medication is metformin. Even after the pharmacotherapy is initiated, lifestyle corrections have to be continued to reduce the possibility of complications (Rodbard et al., 2007) .
CONCLUSIONS
This retrospective study showed that at the moment of diagnosis of T2DM, 54.2% children had dyslipidemia and 66.7% had arterial hypertension. Most of the T2DM pa- tients were girls 71%. Considering, that girls with type 2 diabetes mellitus have high cardiovascular risk in adulthood, it is very important not only to achieve normal glucose levels early, but also to treat comorbidities, to reduce further microvascular and macrovascular complication risk.
